Micafungin activity against Candida albicans with diverse azole resistance phenotypes. - sprookjes - yvandenbroek - TriplyDB

Micafungin activity against Candida albicans with diverse azole resistance phenotypes.

Micafungin activity against Candida albicans with diverse azole resistance phenotypes.

http://www.wikidata.org/entity/Q36867925

about

Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.Characterization, antifungal and cytotoxic evaluation of green synthesized zinc oxide nanoparticles using Ziziphus nummularia leaf extract.Echinocandins in antifungal pharmacotherapy.Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.

P2860

Q28547078-244B3984-65C7-449C-9BA4-FC4B5399E8FE Q34991073-391ECB0A-9582-4477-BDEF-98F36676316E Q35039323-ED1B6196-B9C3-4D48-9F68-EA8621BB00D1 Q36456366-5F6AB484-DF7D-43C5-A6C0-073D5A129346 Q37190686-B596667A-96B1-4CCD-9D72-6F8401962F45 Q37443139-813A7936-995B-4153-82DF-7FC26C0F278F Q38718637-771200AD-B37C-46C0-BD8F-A6F856482D93 Q39458862-074C9498-00B4-4D56-9E0F-9073027178E6 Q40138001-94910651-625E-4309-851B-AC233A39C701 Q40983039-691342BC-2587-4A59-B507-8AA8054DC852

P2860

Micafungin activity against Candida albicans with diverse azole resistance phenotypes.

http://www.wikidata.org/entity/Q36867925

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Micafungin activity against Candida albicans with diverse azole resistance phenotypes.

@en

type

label

Micafungin activity against Candida albicans with diverse azole resistance phenotypes.

@en

prefLabel

Micafungin activity against Candida albicans with diverse azole resistance phenotypes.

@en

P1433

Q36867925-8F5FBC4D-9D44-4C6B-BAD3-C078833606D5

P1476

Q36867925-CC3991A2-A3B4-4307-8B82-63E0E38D0575

P2093

Q36867925-36119E64-EAC4-4317-A111-2CEE8067F66D

Q36867925-A288608B-AE4F-4D85-B8BE-CDBE0EAC6529

Q36867925-A68AD9E1-DD13-41EB-A7C8-31158132C3A3

P2860

Q36867925-033894F1-ED73-4091-81D4-B2660CE5F802

Q36867925-0A010FF0-986D-4AFB-8E57-24AA623520A5

Q36867925-18C4F66C-4A18-4C63-811F-467DBB0E5D85

Q36867925-2409409C-8D7A-4481-BE8E-0811668622AB

Q36867925-2CB7CF51-C68C-40FD-9B17-C32C4511ABF7

Q36867925-3DB32FCE-2702-4FC0-85A0-5A762DF02CE8

Q36867925-4381D45C-2328-49B6-88AC-35D9DE43CC42

Q36867925-46086A75-4722-4F15-B1DA-65E4BC120E31

Q36867925-4D3BC653-091D-4902-B4A9-1DC79F2D5FBF

Q36867925-5123E936-0A55-4F8B-BAC8-ADB326C164E2

P304

Q36867925-45B67039-6181-4371-9255-5F9C0F6854BF

P31

Q36867925-339931B7-98ED-4F29-B10D-8928F77D2CFD

P356

Q36867925-CDEB1E58-6DD9-483A-8842-6EE975C1B25F

P407

Q36867925-AD7402A3-BABF-4CA7-97A4-B7D6CD257C58

P433

Q36867925-FDF58059-BE0D-492F-965F-B6F8722A8306

P478

Q36867925-C4B09EE9-F1B8-4CB0-B846-E7B72B981876

P577

Q36867925-5AA3E258-B735-4AF3-BB87-08DB9CEC7719

P5875

Q36867925-4D995702-314D-4529-A76E-A5A244A4B244

P698

Q36867925-B3FE67B3-9A26-44DD-8F2A-20D76758773F

P932

Q36867925-FE8357F5-510F-4E49-9662-6C1E106F4076

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Micafungin activity against Candida albicans with diverse azole resistance phenotypes.

@en

P2093

Brian G Oliver

http://www.w3.org/2001/XMLSchema#string

Theodore C White

http://www.w3.org/2001/XMLSchema#string

Theresa S Richards

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi

In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole

Echinocandin antifungal drugs

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.

Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.

The trailing end point phenotype in antifungal susceptibility testing is pH dependent

In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies

P304

349-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKN156

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5298113

http://www.w3.org/2001/XMLSchema#string

P698

18436555

http://www.w3.org/2001/XMLSchema#string

P932

2532560

http://www.w3.org/2001/XMLSchema#string